Insight: As Torrent Pharmaceuticals noted, to truly disrupt the entire market, GLP-1s must eventually bridge the massive price gap with existing oral gliptins, which currently cost just ~10 per tablet
Semaglutide is not primarily eliminated by the kidneys
All of my questions and concerns were addressed and explained thoroughly
For researchers whose side effects are dose-dependent and peak-related, this can make a dramatic difference in tolerability
But for Lurie, the argument that demand should inevitably lead to a stamp of approval falls short given the "extremely thin science." "If at the end of the day these products are approved, I see nothing good coming out of it," he said
Women and kidney disease: Reflections on World Kidney Day 2018